Support for Transgender and Non-Binary Individuals Seeking Vaginoplasty Study
Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · May 24, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
OUTLINE The STRIVE (Support for Transgender and Non-Binary Individuals Seeking Vaginoplasty) Study is a multi-site, two-arm randomized pragmatic trial to determine if an evidence-based peer support intervention improves patient-reported and patient-centered clinical outcomes for individuals seeking genital gender-affirming surgery (GGAS) compared with enhanced usual care.
PRIMARY OBJECTIVES Aim 1: To compare the effectiveness of a virtual, group-based perioperative peer support intervention with enhanced usual care on coping self-efficacy (primary outcome) among patients seeking vaginoplas...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Self-identified trans or non-binary individual
- • Seeking vaginoplasty
- • Completed consultation with gender-affirming surgeon for vaginoplasty
- • Documented recommendation by surgeon for vaginoplasty
- • Can complete survey responses online, by phone or on paper.
- • Willing and able to participate in virtual peer support intervention
- • Aged 18 or older
- • English speaking
- • Able to provide independent written consent
- Exclusion Criteria:
- • Do not speak English
- • Cannot complete survey responses online, by phone, or on paper
- • Are unwilling to participate in a virtual peer support intervention
- • Have co-morbidities or other conditions that exclude them from candidacy for vaginoplasty
- • Are currently involved in delivery of the STRIVE Intervention
- • Are unable or unwilling to participate.
About Oregon Health And Science University
Oregon Health and Science University (OHSU) is a leading academic medical center dedicated to advancing health through research, education, and patient care. As a prominent sponsor of clinical trials, OHSU leverages its extensive expertise in various medical fields to facilitate innovative research aimed at improving patient outcomes. The institution is committed to ethical standards and rigorous scientific methodologies, fostering collaborations that enhance the development of new therapies and interventions. With a focus on translating research discoveries into clinical practice, OHSU plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Seattle, Washington, United States
Philadelphia, Pennsylvania, United States
Salt Lake City, Utah, United States
Portland, Oregon, United States
San Francisco, California, United States
Chicago, Illinois, United States
Salt Lake City, Utah, United States
New York, New York, United States
Patients applied
Trial Officials
Geolani Dy, MD
Principal Investigator
Oregon Health and Science University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported